Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma
Listen to Dr Brad Kahl and Dr Noopur Raje discuss the latest advances in CAR T-cell therapy for lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently under development for multiple myeloma.
Decera Clinical Education Oncology Podcast · Noopur Raje MD, Brad Kahl MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently under development for multiple myeloma.
- Lymphomas
- DLBCL: Real-world outcomes post axi-cel, CAR T vs autologous HSCT
- FL: Tisa-cel (ELARA), axi-cel (ZUMA-5)
- MZL: Liso-cel (TRANSCEND FL)
- MCL: Real-world outcomes post brexu-cel
- CLL: Liso-cel (TRANSCEND CLL 004)
- Multiple Myeloma
- Cilta-cel (CARTITUDE-1)
- Anito-cel (iMMagine-1)
- GC012F
- Arlo-cel
- BMS-986453
- TriPRIL
Presenters:
Brad Kahl, MD
Professor of Medicine
Washington University
St Louis, Missouri
Noopur Raje, MD
Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Content based on an online CME program supported by an independent educational grant from Bristol Myers Squibb.
Link to full program:
https://bit.ly/3ViR62V
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.